홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.1
  1. 홈
  2. /화합물

Naltrexone Hydrochloride

HCID 5485201
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
16676-29-2
표준 SMILES
Cl.O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5
InChIKey
RHBRMCOKKKZVRY-ITLPAZOVSA-N
분자식
C20H24ClNO4
평균 분자량
377.9 g/mol
단동위원소 질량
377.13938593

개요

Naltrexone hydrochloride is a hydrochloride obtained by reaction of oxycodone with one molar equivalent of hydrochloric acid. it is a -opioid receptor antagonist that is used to treat alcohol dependence. It has a role as a central nervous system depressant, a mu-opioid receptor antagonist and an antidote to opioid poisoning. It contains a naltrexone(1+).

이름 및 식별자

우선 이름
Naltrexone Hydrochloride
IUPAC
(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride
영어명
Naltrexone hydrochloride
분자식
C20H24ClNO4
분자량
377.87

이름 및 동의어

Naltrexone hydrochloride16676-29-2Naltrexone HclDepadenaltrexone.HClEn 1639AEN-1639AN-Cyclopropylmethyl-noroxymorphone hydrochlorideZ6375YW9SFEN-1639A (AS HYDROCHLORIDE)(5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride17-(Cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-morphinan-6-one hydrochloride
이름 더 보기
ReVianih8503en1639aNalorexAntaxone4-D-butylCcris 1168NSC 409767Nalmefene-3
Naltrexone hydrochloride (USP)Naltrexone hydrochloride [USP]CHEBI:134687DTXSID50937236TROXYCA COMPONENT NALTREXONE HYDROCHLORIDECONTRAVE COMPONENT NALTREXONE HYDROCHLORIDETrexonilRefChem:56740

데이터베이스 식별자

CAS

물성

구조 계산 물성보충 중

극성 표면적
70 Ų
수소 결합 공여자 수
3
수소 결합 수용자 수
5
회전 가능 결합 수
2
무거운 원자 수
26
형식 전하
0
복잡도
621

실험 및 물리화학적 성질

Solubility>56.7 [ug/mL] (The mean of the results at pH 7.4)
Human Drugs · 3건

Breast Feeding; Lactation; Milk, Human; Alcohol Deterrents; Narcotic Antagonists

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Animal DrugsActive Ingredients (Naltrexone Hydrochloride) -> FDA Greenbook
Collision Cross Section176 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
274 · 274-2760C
저장 조건
2 · 2-8°C
용해도
2 O: · H2O: 50 mg/mL, 투명, 무색
물리적 상태
powder
색상
흰색에서 황백색까지
수용성
50 mg/ml로 · 50mg/ml로 물에 용해됩니다.
Merck
13 · 13,6389
BRN
3580333 · 3580333
InChIKey
RHBRMCOKKKZVRY-LNTCFJBQNA-N
SMILES
O[C@]12CCC(=O)[C@]3([H])OC4=C(C=CC5C[C@@]1([H])N(CC1CC1)CC[C@@]23C4=5)O.Cl |&1:1,6,15,24,r|

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H302 (97.6%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P233, P260, P261, P264, P270, P271, P272, P280, P284, P301+P317, P302+P352, P304+P340, P317, P318, P321, P330, P333+P317, P342+P316, P362+P364, P403, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 83 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 4 (97.6%)

독성 정보

TreatmentPatients should be treated symptomatically in a closely supervised environment. (L1712)
Health Effects · 1건

Tolerance can develop, in which the person needs larger doses to achieve the desired effect; this can lead to overdose and death. Accidents or injury can also occur due to the side effects of loss of coordination, slowed reaction time, sleepiness and impaired judgment. Drugs in this category have a high potential for physical and psychological dependence.

Exposure RoutesAlthough well absorbed orally, naltrexone is subject to significant first pass metabolism with oral bioavailability estimates ranging from 5 to 40%.
Toxicity Summary · 1건

Naltrexone is a pure opiate antagonist and has little or no agonist activity. The mechanism of action of naltrexone in alcoholism is not understood; however, involvement of the endogenous opioid system is suggested by preclinical data. Naltrexone is thought to act as a competitive antagonist at mc, kappa, and delta receptors in the CNS, with the highest affintiy for the mu receptor. Naltrexone competitively binds to such receptors and may block the effects of endogenous opioids. This leads to the antagonization of most of the subjective and objective effects of opiates, including respiratory depression, miosis, euphoria, and drug craving. The major metabolite of naltrexone, 6-beta-naltrexol, is also an opiate antagonist and may contribute to the antagonistic activity of the drug.

화학 및 산업

약리 정보

Metabolism/Metabolites · 1건

Hepatic. When administered orally, naltrexone undergoes extensive biotransformation and is metabolized to 6 beta-naltrexol (which may contribute to the therapeutic effect) and other minor metabolites. Route of Elimination: Both parent drug and metabolites are excreted primarily by the kidney (53% to 79% of the dose), however, urinary excretion of unchanged naltrexone accounts for less than 2% of an oral dose and fecal excretion is a minor elimination pathway. The renal clearance for naltrexone ranges from 30 to 127 mL/min and suggests that renal elimination is primarily by glomerular filtration. Half Life: 4 hours for naltrexone and 13 hours for the active metabolite 6 beta-naltrexol.

FDA Pharmacological Classification · 2건

NALTREXONE HYDROCHLORIDE

Opioid Antagonists [MoA]; Opioid Antagonist [EPC]

MeSH Pharmacological Classification · 2건

Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism.

Agents inhibiting the effect of narcotics on the central nervous system.

용도 및 제조

Uses · 1건

Used as an adjunct to a medically supervised behaviour modification program in the maintenance of opiate cessation in individuals who were formerly physically dependent on opiates and who have successfully undergone detoxification. Also used for the management of alcohol dependence in conjunction with a behavioural modification program.

Use ClassificationAnimal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients
응용 분야 · 2건

Naltrexone hydrochloride is a potent, long-acting, orally-effective narcotic antagonist useful in the management of narcotic addiction.

관련 반응

7건
반응 기록 만들기
HRID 430704 반응식
HRID 430704반응물로uspto-grants-2001_11
HRID 567431 반응식
HRID 567431반응물로uspto-grants-2001_01
HRID 651048 반응식
HRID 651048반응물로uspto-grants-2001_08
HRID 845825 반응식
HRID 845825반응물로uspto-grants-1988_07
HRID 845826 반응식
HRID 845826반응물로uspto-grants-1988_07
HRID 1037635 반응식
HRID 1037635생성물로uspto-grants-2013_10
HRID 2370712 반응식
HRID 2370712생성물로uspto-grants-2014_04

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
16676-29-2
PubChem CID
5485201
DTXSID
DTXSID50937236
ChEMBL
CHEMBL1201149
ChEBI
CHEBI:134687
UNII
Z6375YW9SF
EC Number
240-723-0

화학적 성질

White Crystalline Powder

Signs and SymptomsHigh doses of naltrexone (generally ≥1,000 mg/kg) produce salivation, depression/reduced activity, tremors, and convulsions.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Naltrexone hydrochloride

Ambiguous-DILI-concern

3

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Toxicity DataLD50: 1,100-1,550 mg/kg (oral, mouse) LD50: 1,450 mg/kg (oral, rat) LD50: 1,490 mg/kg (oral, guinea pig)

안전 데이터

wgk
3
rtecs
QD2160000
독성
guinea pig,LD50,oral,1490mg/kg (1490mg/kg),Medicamentos de Actualidad. Vol. 21, Pg. 264, 1985.
HS 번호
2932.99.7000
risk_code
22
hazard_code
Xn
safety_code
22-36
F 고인화성물질
8-10
Hazard Classifications
Acute Tox. 4 Oral
스토리지 클래스
11 - Combustible Solids
개요

용도Naltrexone hydrochloride has been used:as an opioid antagonist, to analyse its effect on ethanol preference using Caenorhabditis elegans as a model.to determine its effectiveness in reducing the preference for substance of abuse (SOA) like nicotine and cocaine using Caenorhabditis elegans as a model.in the preparation of combinatorial drug, PXT3003 for treating Charcot-Marie-Tooth disease 1A (CMT1A) transgenic rat model Pmp22.

상·하류 제품 정보

하류 제품

날트렉손3-메틸에테르날트린돌염산염